nySTAT
Home
CBMS
Publications
Projects
Teaching
Software
Phase I/II Clinical Trial
TEAMS: Toxicity- and Efficacy-based Dose Insertion Design with Adaptive Model Selection for Phase I/II Dose-Escalation Trials in Oncology
A dose insertion design for phase I/II clinical trials in oncology based on both efficacy and toxicity outcomes.
Cite
×